TURNOVER (x1000 DKK)
NET PROFIT (x1000 DKK)
EMPLOYEES
Biotage Sweden AB
Closing information (x1000 DKK)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
462,957
|
483,103
|
582,956 |
| Financial expenses |
6,228
|
1
|
20,065 |
| Earnings before taxes |
108,387
|
125,480
|
157,577 |
| EBITDA |
114,549
|
121,121
|
179,471 |
| Total assets |
395,510
|
451,746
|
387,631 |
| Current assets |
389,900
|
444,914
|
379,933 |
| Current liabilities |
231,138
|
172,980
|
178,005 |
| Equity capital |
158,264
|
272,870
|
204,338 |
| - share capital |
2,511
|
2,597
|
2,584 |
| Employees (average) |
85
|
92
|
93 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
40.0%
|
60.4%
|
52.7% |
| Turnover per employee |
5,447
|
5,251
|
6,268 |
| Profit as a percentage of turnover |
23.4%
|
26.0%
|
27.0% |
| Return on assets (ROA) |
29.0%
|
27.8%
|
45.8% |
| Current ratio |
168.7%
|
257.2%
|
213.4% |
| Return on equity (ROE) |
68.5%
|
46.0%
|
77.1% |
| Change turnover |
-4,166
|
-102,856
|
70,445 |
| Change turnover % |
-1%
|
-18%
|
14% |
| Chg. No. of employees |
-7
|
-1
|
-2 |
| Chg. No. of employees % |
-8%
|
-1%
|
-2% |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.